Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bausch Health Companies Inc
(NY:
BHC
)
8.710
+0.090 (+1.04%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Bausch Health Companies Inc
< Previous
1
2
3
4
5
Next >
Bausch Health to Announce First-Quarter 2024 Results on May 2
April 11, 2024
Via
ACCESSWIRE
Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
April 11, 2024
Via
ACCESSWIRE
Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan
April 11, 2024
Via
ACCESSWIRE
Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
April 05, 2024
Via
ACCESSWIRE
Salix Announces 2024 Gastrointestinal Health Scholars Program
February 12, 2024
Via
ACCESSWIRE
CORRECTION BY SOURCE: Solta Medical's Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China
January 18, 2024
Via
ACCESSWIRE
Solta Medical’s Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China
January 18, 2024
Via
ACCESSWIRE
Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) (budesonide) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to Moderate Distal Ulcerative Colitis in Adults
April 03, 2024
Via
ACCESSWIRE
Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations
April 02, 2024
Via
ACCESSWIRE
Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R) (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma
March 06, 2024
Via
ACCESSWIRE
New Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How To Prepare for the Procedure
March 05, 2024
Via
ACCESSWIRE
Bausch Health Companies to Present at Cowen Annual Health Care Conference
March 01, 2024
Via
ACCESSWIRE
Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis
December 21, 2023
Via
ACCESSWIRE
Bausch Health Unveils "Looking Forward" - A New DTC Television Campaign for Seasonal Affective Disorder (SAD)
October 26, 2023
Via
ACCESSWIRE
Bausch Health Announces Fourth-Quarter and Full-Year 2023 Results
February 22, 2024
Via
ACCESSWIRE
Bausch Health Announces Board Refreshment
February 01, 2024
Via
ACCESSWIRE
Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22
February 01, 2024
Via
ACCESSWIRE
CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S.
January 30, 2024
Via
ACCESSWIRE
Court of Appeals for the Federal Circuit Hears Oral Arguments on Patent Dispute
January 07, 2024
Via
ACCESSWIRE
DUOBRII(TM) Lotion to Treat Moderate to Severe Plaque Psoriasis Now Available Through Quebec’s Public Drug Plan
December 18, 2023
Via
ACCESSWIRE
3 cheap 'stock'-ing stuffers Wall Street is bullish on
December 07, 2023
These three companies have Wall Street feeling bullish and are trading under $10, making them ideal ‘stock'-ing stuffers for hard to shop for traders.
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
Salix in Collaboration with The U.S. Pain Foundation and the International Foundation for Gastrointestinal Disorders Establish the Inaugural Opioid-Induced Constipation (OIC) Awareness Day
December 05, 2023
Via
ACCESSWIRE
Bausch Health Companies Inc. (NYSE:BHC) Long Term Shareholder Notice: Investigation of Potential Wrongdoing
December 01, 2023
San Diego, CA -- (SBWIRE) -- 12/01/2023 -- An investigation on behalf of current long-term investors in shares of Bausch Health Companies Inc. (NYSE:BHC) concerning potential breaches of fiduciary...
Via
SBWire
The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis
November 10, 2023
Via
ACCESSWIRE
CORRECTION BY SOURCE: The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis
November 10, 2023
Via
ACCESSWIRE
As Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder (SAD)
November 08, 2023
Via
ACCESSWIRE
Bausch Health Announces Third-Quarter 2023 Results
November 02, 2023
Via
ACCESSWIRE
U.S. District Court Dismisses Norwich's Lawsuit Against the FDA
November 01, 2023
Via
ACCESSWIRE
FDA Approves Cabtreo(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) Topical Gel for the Treatment of Acne Vulgaris in Patients Twelve Years of Age and Older
October 20, 2023
Via
ACCESSWIRE
New Analysis Indicates That a Majority of Overt Hepatic Encephalopathy (OHE) Patients May Face Delays in Treatment Initiation and Gaps During Treatment for Access to Treatment Indicated to Reduce Risk for OHE Recurrence
October 17, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.